Inflammatory Drug-Resistant Epilepsy Index (IDREI) as a Molecular Compound Biomarker in Focal Epilepsies
The IDREI molecular index shows promise in predicting epilepsy and drug-resistant epilepsy (DRE). Additional prospective studies are required to assess its clinical utility.
Authors
- Jesús Ortega-Pinazo (ORCID: https://orcid.org/0000-0002-2884-9239)
- Teresa Ramírez-García (ORCID: https://orcid.org/0009-0000-5207-1159)
- Yolanda López-Moreno (ORCID: https://orcid.org/0000-0003-2861-5915)
- Pedro Jesús Serrano-Castro (ORCID: https://orcid.org/0000-0002-3414-2707)
- María José Aguilar-Castillo (ORCID: https://orcid.org/0000-0002-4021-6880)
- Guillermina García Martín (ORCID: https://orcid.org/0000-0003-3894-9716)
- Guillermo Estivill‐Torrús (ORCID: https://orcid.org/0000-0002-7124-2678)
- Nicolás Lundahl Ciano-Petersen (ORCID: https://orcid.org/0000-0001-9555-4847)
- Pablo Cabezudo‐García (ORCID: https://orcid.org/0000-0002-6421-5348)
Institutions
- Hospital Regional Universitario de Málaga (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Biomolecules
- Published
- 2025-06-22
- DOI
- https://doi.org/10.3390/biom15070914
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47